{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "exchange": "CXE", "shortName": "Hikma Pharmaceuticals PLC", "longName": "Hikma Pharmaceuticals PLC", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChangePercent": -0.026874498, "regularMarketPrice": 1860.0, "marketState": "CLOSED", "firstTradeDateMilliseconds": 1681887600000, "priceHint": 2, "epsTrailingTwelveMonths": 0.66, "sharesOutstanding": 220700000, "bookValue": 9.694, "fiftyDayAverage": 18.365625, "fiftyDayAverageChange": 1841.6344, "fiftyDayAverageChangePercent": 100.27616, "twoHundredDayAverage": 18.365625, "twoHundredDayAverageChange": 1841.6344, "twoHundredDayAverageChangePercent": 100.27616, "marketCap": 410706608128, "priceToBook": 191.87126, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.5, "regularMarketTime": 1683905387, "regularMarketDayHigh": 1865.0, "regularMarketDayRange": "1853.75 - 1865.0", "regularMarketDayLow": 1853.75, "regularMarketVolume": 94227, "regularMarketPreviousClose": 1860.5, "bid": 1860.0, "ask": 1860.5, "fullExchangeName": "Cboe UK", "financialCurrency": "USD", "regularMarketOpen": 1861.0, "averageDailyVolume3Month": 88115, "averageDailyVolume10Day": 101164, "fiftyTwoWeekLowChange": 1842.44, "fiftyTwoWeekLowChangePercent": 104.922554, "fiftyTwoWeekRange": "17.56 - 1865.0", "fiftyTwoWeekHighChange": -5.0, "fiftyTwoWeekHighChangePercent": -0.0026809652, "fiftyTwoWeekLow": 17.56, "fiftyTwoWeekHigh": 1865.0, "earningsTimestamp": 1691047800, "earningsTimestampStart": 1691047800, "earningsTimestampEnd": 1691047800, "trailingAnnualDividendRate": 0.56, "trailingPE": 2818.1816, "trailingAnnualDividendYield": 0.00030099435, "symbol": "HIKL.XC"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1 New Burlington Place", "city": "London", "zip": "W1S 2HR", "country": "United Kingdom", "phone": "44 20 7399 2760", "fax": "44 20 7399 2761", "website": "https://www.hikma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 8800, "companyOfficers": [{"maxAge": 1, "name": "Engineer Said Samih Taleb Darwazah", "age": 65, "title": "Exec. Chairman & CEO", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 2968886, "fmt": "2.97M", "longFmt": "2,968,886"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mazen Samih Taleb Darwazah", "age": 64, "title": "Exec. Vice Chairman & Pres of MENA", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 1951010, "fmt": "1.95M", "longFmt": "1,951,010"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Khalid Waleed Hosny Al Nabilsi", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Guy  Featherstone", "title": "Associate Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hussein  Arkhagha", "title": "Company Sec. & Chief Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bassam Wael Rushdi Kanaan CFA, CPA", "age": 57, "title": "Exec. VP of Corp. Devel. and M&A", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susan  Ringdal", "title": "Exec. VP of Strategic Planning & Global Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Majda  Labadi", "title": "Exec. VP of Organisational Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Riad  Mishlawi", "title": "Pres of Injectables", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brian  Hoffmann", "title": "Pres of Generics", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 5, "compensationRisk": 3, "shareHolderRightsRisk": 1, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}